Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Artificial Cells Nanomedicine and Biotechnology

• Publication date

  2017-12-28

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1080/21691401.2017.1420073PMID 29282995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development and characterization of embelin-loaded nanolipid carriers for brain targeting

  2017cited by this paper
• Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses.

  2016cited by this paper
• Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment

  2016cited by this paper
• Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study

  2016cited by this paper
• Optimization of artemether-loaded NLC for intranasal delivery using central composite design

  2015cited by this paper
• Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration.

  2015cited by this paper
• Insights into direct nose to brain delivery: current status and future perspective

  2014cited by this paper
• Paracrine signalling of inflammatory cytokines from an in vitro blood brain barrier model upon exposure to polymeric nanoparticles.

  2014cited by this paper
• Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug.

  2014cited by this paper
• Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus.

  2013cited by this paper
• Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.

  2013cited by this paper
• Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood

  2013cited by this paper
• Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain.

  2012cited by this paper
• Intranasal delivery of biologics to the central nervous system.

  2012cited by this paper
• Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study

  2012cited by this paper
• Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.

  2012cited by this paper
• Demonstration of an Olfactory Bulb–Brain Translocation Pathway for ZnO Nanoparticles in Rodent Cells In Vitro and In Vivo

  2012cited by this paper
• Brain distribution of ribavirin after intranasal administration.

  2011cited by this paper
• Effects of titanium dioxide nano-particles on growth and some histological parameters of zebrafish (Danio rerio) after a long-term exposure.

  2011cited by this paper
• Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model

  2011cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• Potential of nanoparticulate drug delivery systems by intranasal administration.

  2010cited by this paper
• Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

  2010influential reference
• Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System

  2009cited by this paper
• Nanoparticles: pharmacological and toxicological significance

  2007cited by this paper
• Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology.

  2007cited by this paper
• Drug Delivery Across the Blood-Brain Barrier

  2005cited by this paper
• Medicinal chemical properties of successful central nervous system drugs

  2005cited by this paper
• Drug delivery across the blood-brain barrier.

  2004cited by this paper
• The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats.

  2004cited by this paper
• Freeze-fracture and tracer experiments on the permeability of the zonulae occludentes in the olfactory mucosa of vertebrates

  2004cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Trigeminal collaterals in the nasal epithelium and olfactory bulb: A potential route for direct modulation of olfactory information by trigeminal stimuli

  2002cited by this paper
• Permeability issues in nasal drug delivery.

  2002cited by this paper
• Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.

  2001cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.

  1999cited by this paper
• Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway

  1998cited by this paper
• Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?

  1998cited by this paper
• Delivery of 125I-NGF to the Brain via the Olfactory Route

  1997cited by this paper
• Quantitative analysis of the olfactory pathway for drug delivery to the brain.

  1995cited by this paper
• The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery

  1991cited by this paper
• Nasal absorption of tetraethylammonium in rats.

  1989cited by this paper
• International Journal of Nanomedicine Dovepress Nano-zinc Oxide Damages Spatial Cognition Capability via Over-enhanced Long-term Potentiation in Hippocampus of Wistar Rats

  year unknowncited by this paper

• Quality by design (QbD)-guided development of PEGylated nanostructured lipid carriers of donepezil for intranasal delivery.

  2026cites this paper
• Intranasal delivery of therapeutics to degenerating brain regions: From pathways to nanocarriers

  2026cites this paper
• Lumbrokinase modulates tissue plasminogen activator and alleviates behavioral and cognitive deficits in mice with chronic social defeat stress.

  2026cites this paper
• Advances in nanocarrier-based nose-to-brain drug delivery systems for neurological disorders - A comprehensive review

  2026cites this paper
• Chitosan nanoparticles for brain targeted nose-to-brain drug delivery in neurodegenerative disease: a comprehensive exploration of advances, limitations and future prospects.

  2026cites this paper
• Smog, sugar, and synapses: Unraveling the PM2.5-insulin resistance-Alzheimer’s disease axis

  2026cites this paper
• From Nose to Neurons: The Emerging Role of Dissolving Microneedles in Neurodegenerative Disease Management

  2026cites this paper
• Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases.

  2026cites this paper
• A Comprehensive Review of Nanoemulsion Via the Nose To the Brain in the Management of Parkinson’s Disease

  2025cites this paper
• An overview of nanostructured lipid carriers containing phytoconstituents.

  2025cites this paper
• Nose-to-brain translocation of inhaled ultrafine elongated particles: facts and mysteries

  2025cites this paper
• Nanoparticle-Enhanced Intranasal Drug Delivery: A Novel Strategy for Efficient Brain Targeting in Ischemic Stroke

  2025cites this paper
• Challenges and strategies for nose-to-brain delivery in treating neurological disorders

  2025cites this paper
• Optimized Lacosamide Nanostructured Lipid Carriers for Enhanced Brain Targeting Via the Intranasal Route

  2025cites this paper
• An overview of intranasal drug delivery systems for Alzheimer’s disease

  2025cites this paper
• Cell Membrane- and Vesicle-Based Bionic Nanodrugs: Applications in Central Nervous System Diseases and Exploration of Nasal–Cerebral Delivery

  2025influential citation
• Optimization of cationic functionalized nanoparticles for brain targeting: in vivo evaluation.

  2025cites this paper
• Progress in nasal drug delivery research based on biomaterials

  2025cites this paper
• Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery

  2025cites this paper
• Spanlastics for Targeted CNS Drug Delivery

  2025cites this paper
• Intranasal delivery systems for traumatic brain injury: Advancements and perspectives

  2025cites this paper
• Differential cannabinoid-like effects, receptor affinity and physiologically based pharmacokinetics of the synthetic cannabinoids 4F-MDMB-BINACA, 4F-MDMB-BICA and 5F-MDMB-PICA in mice: A comparative study.

  2025cites this paper
• Nanoparticles Navigating the Intranasal Route: Innovative Approaches in Neurodegenerative Diseases

  2025cites this paper
• From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape

  2025cites this paper
• Intranasal administration of temozolomide conjugated nanoparticles with transcranial magnetic stimulation improves the survival in glioblastoma xenograft models

  2025cites this paper
• Intranasal delivery of drug-loaded polymeric nanomicelles for brain targeting: a comprehensive review

  2025cites this paper
• Breaking the Brain Barrier: Hybrid Nanoparticle-Enabled Delivery for Next-Gen Neurotherapeutics

  2025cites this paper
• Indoor ultrafine particles entering human respiratory regions: defining an index for maximum deposition dose probability in a university classroom case study

  2025cites this paper
• Role of natural plant extracts and hyaluronic acid derivatives in intranasal strategies for brain delivery. A review.

  2025cites this paper
• Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration

  2025cites this paper
• Intranasal delivery of drugs to the central nervous system of adult zebrafish

  2025cites this paper
• The review of nasal drug delivery system: The strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption.

  2025cites this paper
• Nose to brain delivery of insulin loaded in PLGA and Chitosan-Coated PLGA Nanoparticles: A Promising Approach for Alzheimer’s disease therapy

  2025cites this paper
• Intranasal and inhaled delivery systems for targeting circadian dysfunction in neurodegenerative disorders, perspective and future outlook.

  2025cites this paper
• Self-Assembled systems for Nose-to-Brain delivery of Temozolamide (TMZ) in brain tumor therapy.

  2025cites this paper
• Inhaled Lead Nanoparticles Enter the Brain through the Olfactory Pathway and Induce Neurodegenerative Changes Resembling Tauopathies.

  2025cites this paper
• Nose-to-brain delivery of gold nanozyme with cascade effect for bacterial meningitis therapy

  2025cites this paper
• Recent advances on brain drug delivery via nanoparticles: alternative future materials for neuroscience applications; a review

  2025cites this paper
• Intranasal Delivery of a Ghrelin Mimetic Engages the Brain Ghrelin Signaling System in Mice

  2025cites this paper
• Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy

  2025influential citation
• Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights

  2025cites this paper
• Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway.

  2024cites this paper
• Rivastigmine Nasal Spray for the Treatment of Alzheimer's Disease: Olfactory Deposition and Brain Delivery.

  2024cites this paper
• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis

  2024cites this paper
• Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases.

  2024cites this paper
• Evaluation of betanin‐loaded liposomal nanocarriers in AlCl3‐induced Alzheimer's disease in rats: Impact on cognitive function, neurodegeneration, and TREM2/ADAM10 pathways

  2024cites this paper
• A narrative review on potential applications of spanlastics for nose-to-brain delivery of therapeutically active agents.

  2024cites this paper
• Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

  2024cites this paper
• Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan.

  2024cites this paper
• Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review

  2024cites this paper
• Advancement in the nose-to-brain drug delivery of FDA-approved drugs for the better management of depression and psychiatric disorders.

  2024cites this paper
• Paroxetine Loaded Nanostructured Lipid Carriers Based In-situ Gel for Brain Delivery via Nasal Route for Enhanced Anti-Depressant Effect: In Vitro Prospect and In Vivo Efficacy

  2024cites this paper
• Demystifying the Potential of Embelin-Loaded Nanoformulations: a Comprehensive Review

  2024cites this paper
• RETRACTED ARTICLE: A promise of nose to brain delivery of bevacizumab intranasal sol–gel formulation substantiated in rat C6 glioma model

  2024cites this paper
• To Explore Nasal-Brain Lymphatic System for Brain-Targeted Drug Delivery and to Treat Neurodegenerative Diseases.

  2024cites this paper
• Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway

  2024cites this paper
• PLGA Nanoparticles Based Mucoadhesive Nasal In Situ Gel for Enhanced Brain Delivery of Topiramate

  2024cites this paper
• In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders.

  2024cites this paper
• Development and Optimization of Nasal Composition of a Neuroprotective Agent for Use in Neonatology after Prenatal Hypoxia

  2024cites this paper
• Intranasal delivery of doxepin: enhancing brain targeting efficiency utilizing nanostructured lipid carriers for a biopharmaceutics drug disposition classification system class-I drug

  2024cites this paper
• Intranasal delivery of Chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: a comprehensive review of advanced strategies for CNS targeting

  2024cites this paper
• Targeted Delivery of Macrophage Membrane Biomimetic Liposomes Through Intranasal Administration for Treatment of Ischemic Stroke

  2024cites this paper
• Nanocarriers-mediated nose-to-brain drug delivery: A novel approach for the management of Alzheimer’s Disease

  2024cites this paper
• Nose-to-brain drug delivery by HS15 micelles for brain targeting of insoluble drug

  2024cites this paper
• Development of Nanomedicines for the Treatment of Alzheimer's Disease: Raison d'être, Strategies, Challenges and Regulatory Aspects.

  2024cites this paper
• A Review on Lipid-Based Nanoformulations for Targeting Brain through Non-invasive Nasal Route.

  2024cites this paper
• Research progress on intranasal treatment for Parkinson's disease

  2024cites this paper
• Curcumin/TGF-β1 siRNA loaded solid lipid nanoparticles alleviate cerebral injury after intracerebral hemorrhage by transnasal brain targeting.

  2024cites this paper
• Delivery of nose to brain in the management of cerebral vasospasm in aneurysmal subarachnoid hemorrhage

  2024cites this paper
• Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions

  2023cites this paper
• Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery

  2023influential citation
• Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting

  2023cites this paper
• Preparation of an HI-6-loaded brain-targeted liposomes based on the nasal delivery route and the evaluation of its reactivation of central toxic acetylcholinesterase.

  2023cites this paper
• In vitro Evaluation of Paliperidone Palmitate Loaded Cubosomes Effective for Nasal-to-Brain Delivery

  2023cites this paper
• Transcranial application of magnetic pulses for improving brain drug delivery efficiency via intranasal injection of magnetic nanoparticles

  2023cites this paper
• Nanoscale Zinc-Based Metal-Organic Frameworks Induce Neurotoxicity by Disturbing the Metabolism of Catecholamine Neurotransmitters.

  2023cites this paper
• Super disintegrating oromucosal nanofiber patch of zolmitriptan for rapid delivery and efficient brain targeting

  2023cites this paper
• Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease.

  2023cites this paper
• Nose-to-Brain delivery of donepezil hydrochloride following administration of an HPMC-Me-β-CD-PEG400 nasal film in mice

  2023cites this paper
• A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide—A Dihydro-Orotate Dehydrogenase Inhibitor and an miR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse

  2023influential citation
• Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND).

  2023cites this paper
• Intranasal spray of cubosomal tizanidine hydrochloride for brain targeting: in vitro and in vivo characterisation

  2023cites this paper
• Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications

  2023cites this paper
• Development of mucoadhesive in-situ nasal gel formulation for enhanced bioavailability and efficacy of rizatriptan in migraine treatment

  2023cites this paper
• Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs

  2023cites this paper
• Recent advances in nanotechnology for Intra-nasal drug delivery and clinical applications

  2023cites this paper
• SOLID LIPID NANOPARTILCES: MODERN PROGRESS IN NOSE-TO-BRAIN TRANSDUCTION

  2023cites this paper
• Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation

  2023cites this paper
• Simulation of nanocarrier-based targeted delivery of an antidepressant for major depressive disorder

  2023cites this paper
• Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases

  2023cites this paper
• Stimuli-responsive nanoparticles delivered by a nasal-brain pathway alleviate depression-like behavior through extensively scavenging ROS.

  2023cites this paper
• Environmental exposure disparities in ultrafine particles and PM2.5 by urbanicity and socio-demographics in New York state, 2013–2020

  2023cites this paper
• Nanotechnology-based Nose-to-brain Delivery in Epilepsy: A Novel Approach to Diagnosis and Treatment.

  2023cites this paper
• Neuroinflammation in Alzheimer’s Disease: A Potential Role of Nose-Picking in Pathogen Entry via the Olfactory System?

  2023cites this paper
• Brain targeting of drugs via intranasal route in conjunction with nanoparticle-based systems: an updated review

  2023cites this paper
• THE DEVELOPMENT OF A BRAIN TARGETED MUCOADHESIVE AMISULPRIDE LOADED NANOSTRUCTURED LIPID CARRIER

  2023cites this paper
• Bi‐directional nasal drug delivery systems: A scoping review of nasal particle deposition patterns and clinical application

  2023cites this paper
• Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management

  2023cites this paper
• Modulation of olfactory area for effective transportation of actives in CNS disorders

  2022cites this paper
• Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review

  2022cites this paper